cover of a federal indictment

Case overview, USA v Capsulcn International Co Ltd et al

May 13, 2025
Posted in

In May 2025, the U.S. District Court in the Western District of Texas unsealed an indictment against a CapsulCN International and three Chinese nationals for their alleged role in the illegal importation of pill-making equipment.

Read More
cover of a federal indictment

Indictment, USA v CapsulCN International Co Ltd et al

May 13, 2025
Posted in , , , , , , , ,

April 23, 2025

Read More

May 12, 2025: FDA will expand unannounced foreign facility inspections, it says

May 12, 2025
Posted in ,

The FDA wants to ensure that domestic and foreign companies receive the same level of regulatory oversight.

Catch up on research PSM released about medicines imported from unregistered sources.

Read More

Prescription Drug Freight Fraud Report, March 2025

May 12, 2025
Posted in , ,

What if your blood thinners were made in an unverified location in Colombia? In March 2025, dozens of pharmaceutical shipments entered the U.S. that were manufactured in places no one would expect.

Read More

Pharmaceutical Border Security

May 9, 2025
Posted in

Pharmaceutical border security Every day, inspectors from Customs and Border Protection, the Food and Drug Administration, and the Drug Enforcement Administration intercept scary medical products  entering the U.S. This work is incredibly important to protect the safety of American patients and it’s difficult because criminals never stop innovating. PSM supports the work of border inspectors by commenting on proposed rules,…

Read More

Case overview, Gilead Sciences v Heal the World et al

May 9, 2025
Posted in

Gilead Sciences has filed a civil complaint against a Queens, New York-based pharmacy that allegedly sold counterfeit HIV medicine.

Read More
front page is a document

Oregon State Pharmacy Association submits testimony to Oregon’s PDAB

May 7, 2025
Posted in

Oregon State Pharmacy Association submits testimony to Oregon’s PDAB On May 6, the Oregon State Pharmacy Association (OSPA) submitted testimony for the Oregon Prescription Drug Affordability Board’s May 2025 meeting, suggesting that the board eliminate PBM spread pricing to improve prescription drug affordability.  Read it here. Read the PDF. Learn more about: Upper payment limits PBM reimbursement practices Visit PSM’s…

Read More

Prescription Drug Affordability Board Activity, April 17 – April 30, 2025

May 6, 2025
Posted in ,

Prescription Drug Affordability Board Activity, April 17 – April 30, 2025 Activities Summary Colorado: Colorado’s PDAB updated the Colorado Prescription Drug Affordability Advisory Council on its progress on April 24, 2025. Conversation focused on gathering stakeholder feedback. Maryland: Maryland’s Prescription Drug Affordability Advisory Council met on April 28,2025 to hear an expert presentation about Drug Pricing and the Supply Chain…

Read More
graph comparing negative health effects between compounded and manufactured glp-1s

May 4, 2025: New study suggests more adverse events associated with compounded GLP-1s than standard formulations

May 5, 2025
Posted in

New research shows a correlation between compounded weight loss and diabetes injectables and increased adverse events. GIlead Sciences is suing another New York City pharmacy that allegedly sold counterfeit HIV medicine.

Read More

ALERT: New FDA Warning Letter to www.thesafepills.org

April 29, 2025
Posted in ,

The FDA has issued a warning to the operators of the online pharmacy www.thesafepills.org for illegally selling unapproved and misbranded opioid medications, including tapentadol products marketed as Aspadol and Typendol. These unauthorized drugs, sold without a prescription, pose significant health risks such as overdose, addiction, and even death.

Read More